NEWS
CONFERENCES
MEDIA
PUBLICATIONS
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
SUBSCRIBE

Your AI-Trained Oncology Knowledge Connection!

Metastatic Prostate Cancer with Charles Ryan, MD and William K. Oh, MD: Case 2

EP. 1: Charles Ryan, MD: The Role of Chemotherapy and Local Therapy

July 19th 2016

EP. 2: Charles Ryan, MD: Bone-Targeted Therapy

July 19th 2016

EP. 3: Charles Ryan, MD: Follow-Up Recommendations During and After Treatment

July 19th 2016

EP. 4: Charles Ryan, MD: Comparison of Chemotherapy to a Secondary Hormone at the Time of Progression

July 19th 2016

EP. 5: Charles Ryan, MD: The Role of Abiraterone Plus Prednisone in Patients With Diabetes

July 19th 2016

EP. 6: William Oh, MD: The Role of Chemotherapy and Local Therapy

July 19th 2016

EP. 7: William Oh, MD: Bone-Targeted Therapy

July 19th 2016

EP. 8: William Oh, MD: Follow-Up Recommendations During and After Treatment

July 19th 2016

EP. 9: William Oh, MD: Comparison of Chemotherapy to a Secondary Hormone at the Time of Progression

July 19th 2016

EP. 10: William Oh, MD: The Role of Abiraterone Plus Prednisone in Patients With Diabetes

July 19th 2016

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Addition of Lurbinectedin Improves Duration of Maintenance in ES-SCLC

Physical Activity: A Potential Pathway for Reducing Fatigue in Colorectal Cancer

FDA Orphan Drug Designation Given to NP-G2-044 in Pancreatic Cancer

mFOLFOX/Bevacizumab/Atezolizumab Improves PFS in dMMR/MSI-H Colorectal Cancer

Phase I Trial of Neoantigen Vaccine Shows 100% DFS Rate in HNSCC